Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study
暂无分享,去创建一个
C. Forsblom | P. Groop | O. B. O. T. I. Group | V. Harjutsalo | L. Thorn | J. Wadén | M. Saraheimo | F. Jansson | A. Ahola | Nina Elonen
[1] A. Paterson,et al. Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study. , 2016, Clinical journal of the American Society of Nephrology : CJASN.
[2] B. Zinman,et al. Renal outcomes in patients with type 1 diabetes and macroalbuminuria. , 2014, Journal of the American Society of Nephrology : JASN.
[3] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[4] Merlin C. Thomas,et al. The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.
[5] T. Uzu,et al. Reduction in Microalbuminuria as an Integrated Indicator for Renal and Cardiovascular Risk Reduction in Patients With Type 2 Diabetes , 2007, Diabetes.
[6] K. Isshiki,et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. , 2005, Diabetes.
[7] Merlin C. Thomas,et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). , 2005, Diabetes care.
[8] M. Nieminen,et al. Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study , 2005, Hypertension.
[9] O. Pedersen,et al. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] B. Brenner,et al. Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy , 2004, Circulation.
[11] N. Chaturvedi,et al. Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study , 2004, Diabetologia.
[12] L. Sechi,et al. Regression of microalbuminuria in type 1 diabetes. , 2003, The New England journal of medicine.
[13] Hans L Hillege,et al. Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.
[14] H. Parving,et al. Remission of nephrotic-range albuminuria in type 1 diabetic patients. , 2001, Diabetes care.
[15] H. Parving,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.
[16] H. Parving,et al. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. , 2001, Kidney international.
[17] G. Viberti,et al. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. , 2000, Diabetes care.
[18] J. Chan,et al. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. , 2000, Kidney international.
[19] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[20] J. Tuomilehto,et al. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland , 1998, Diabetologia.
[21] K Borch-Johnsen,et al. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study , 1996, BMJ.
[22] J. Wikstrand,et al. Urinary albumin excretion--a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. , 1996, American journal of hypertension.
[23] K. Forrest,et al. The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] K. Borch-Johnsen,et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes , 1996, BMJ.
[25] S. Greenhouse,et al. Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group. , 1994, Kidney international.
[26] S. Kreiner,et al. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. , 1987, British medical journal.
[27] C. Mogensen,et al. Predicting diabetic nephropathy in insulin-dependent patients. , 1984, The New England journal of medicine.
[28] H. Parving,et al. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. , 1982, Acta endocrinologica.
[29] H. Keen,et al. MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.
[30] J. Kirkpatrick. Albuminuria and Risk of Cardiovascular Events , Death , and Heart Failure in Diabetic and Nondiabetic Individuals , 2002 .